BioNTech
The Director MS&T at BioNTech will serve as the technical voice for late‑stage and commercial RNA and antibody products, ensuring regulatory compliance and driving technical excellence from process performance qualification through launch and lifecycle management. The role leads technical transfer, Biologics License Application readiness, and post‑approval change management while coordinating with strategic partners and internal cross‑functional teams.
Headquarters
Mainz, Rhineland-Palatinate, Germany
Company Size
1001-5000 employees
Founded
2008
BioNTech is a biotechnology company that develops mRNA-based cancer immunotherapies, next-generation immunomodulators and targeted oncology therapies, and vaccines against infectious diseases. It combines proprietary mRNA, cell- and gene-based platforms to design both individualized and off-the-shelf treatments and advance programs through preclinical and clinical development. The company gained global prominence through its collaboration with Pfizer on an mRNA COVID-19 vaccine and pursues broad partnerships and scaled manufacturing to bring therapies to patients worldwide. BioNTech emphasizes translational science and personalized medicine to transform outcomes in oncology and infectious disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BioNTech.
BioNTech didn’t post a salary, so this is our estimate from similar listings.
24% below the average for this role
Director, CMC – Biologics & ADC
Pathos
(Senior) CMC Specialist, Upstream Processing, Lifecycle Management
Genmab
Senior Manager, MS&T
Catalent
Associate Director, Technical Operations, Biologics Drug Substance Manufacturing
Travere Therapeutics
Specialist– MS&T
Novartis
Director / Principal Scientist, Biologics Drug Substance Commercialization (BDSC)
MSD